Ibuprofen suspension: pediatric antipyretic

Area of Science:

• Pediatrics
• Pharmacology
• Clinical Medicine

Background:

• Pediatric ibuprofen suspension has been a prescription medication for fever relief in children aged 6 months and older since 1989.
• Existing data suggests potential for use in younger infants.

Purpose of the Study:

• To evaluate the safety and efficacy of pediatric ibuprofen suspension as an antipyretic in children as young as 3 months of age.
• To compare the efficacy of ibuprofen with acetaminophen in pediatric fever management.

Main Methods:

• A review of several studies was conducted.
• Efficacy was assessed based on the speed and duration of fever reduction.
• Comparison was made between ibuprofen and acetaminophen at equivalent doses (10 mg/kg).

Main Results:

• Ibuprofen demonstrated safety and effectiveness as an antipyretic in children as young as 3 months.
• Doses of 10 mg/kg provided more rapid and longer-lasting fever reduction compared to the same dose of acetaminophen.
• This effect was particularly notable in children with high fevers (≥101.9°F).

Conclusions:

• Pediatric ibuprofen suspension is a safe and effective antipyretic for children from 3 months of age.
• Ibuprofen offers advantages over acetaminophen in terms of speed and duration of fever reduction, especially for high fevers.
• These findings support the consideration of over-the-counter availability for pediatric ibuprofen suspension.